Antibiotice Iași: One of the most used antibiotics in pandemic won the auction organized by the European Commission


The fight against the SARS-CoV-2 virus has led Europe to take safety measures against stocks of beta-lactam antibiotics administered by doctors around the world to treat Covid-19-associated infections.

Thus, the European Commission recently completed the auction to provide Member States with the necessary stocks for the second wave of the pandemic with beta-lactam antibiotics (amoxicillin with clavulanic acid and piperacycline with tazobactam).

Antibiotice Iași won this auction for the product AmoxiPlus® (amoxicillin / clavulanic acid – sterile injectable powder) and will deliver, at the request of European countries, 2,750,000 vials, in a period of 12 months.

“I think each of us has to do what he knows best. Antibiotice provides Europe with a strategic product of the utmost importance for the treatment of COVID-19 associated infections. We won the auction with a common sense price, giving European countries accessibility to this product. Amoxicillin with clavulanate is one of the most valuable drugs for fighting bacterial infections and more. We at Antibiotice have 65 years of experience and know-how in the production of sterile injectable powders. However, beyond providing the necessary AmoxiPlus® for European markets, deliveries will be made primarily to cover the need for anti-infective drugs for patients in Romania. We respect our contracts, ensuring the continuity of deliveries to our national partners “stated Ioan Nani, CEO Antibiotice Iași.

Amoxicillin with clavulanic acid, along with piperacillin with tazobactam, are the main products recommended by the World Health Organization in anti-infective treatment.

Winning the auction involved obtaining a maximum score by cumulatively meeting four essential conditions: quality, shelf life, price, speed / prompt delivery.

Antibiotice is the only pharmaceutical company in Romania that has a production flow for sterile injectable powders, the first product being manufactured in 1955. The quality standards implemented on this production flow have been recognized and approved by the US FDA (Food and Drug Administration). Produced for over 30 years, this superior generation antibiotic is sold by Antibiotice Iași in hospitals in Romania, Great Britain, Vietnam, Hungary, Lithuania, Iraq, Yemen.


Released 10.16.2020


See all news ▸